Cardiovascular Disease Doctors in Exeter, NH Accepting Medicare

8 Cardiovascular Disease doctors found. Showing 1 - 8

Dr. Gregory M Goodkin, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Alumni Dr Ste 101, Exeter, NH 03833 Phone: 603-773-9992    Fax: 603-778-6393

Miss Jessica Arlene Sutherland, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Alumni Dr Ste 101, Exeter, NH 03833 Phone: 603-773-9992    Fax: 603-778-6393

Dr. Brian Story Porter, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Alumni Dr Ste 101, Exeter, NH 03833 Phone: 603-773-9992    Fax: 603-778-6393

Ernest J Podrasky, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Alumni Dr Ste 101, Exeter, NH 03833 Phone: 603-772-9992    Fax: 603-778-6393

Dr. Alan R Gladstone, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3 Alumni Dr, Ste 101, Exeter, NH 03833 Phone: 603-773-9992    Fax: 603-778-6393

Dr. William G Berndt, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Alumni Dr Ste 101, Exeter, NH 03833 Phone: 603-773-9992    Fax: 603-778-6393

Dr. Russell R Fiore, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 36 Meadowood Dr, Exeter, NH 03833 Phone: 603-778-0055    Fax: 603-778-0666

Dr. Alice A. Passer, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3 Alumni Dr, Ste 101, Exeter, NH 03833 Phone: 603-773-9992    Fax: 603-778-6393

News Archive

Professor receives $1.7M NIH grant to explore novel treatments for chronic methamphetamine users

A Wayne State University professor recently received a nearly $1.7 million grant from the National Institutes of Drug Abuse of the National Institutes of Health to explore whether proteasome and parkin — two components of the ubiquitin-proteasome system — are potential pharmaceutical drug targets that can be manipulated to promote survival and recovery of dopaminergic terminals after binge and chronic administration of toxic doses of methamphetamine.

Osteoarthritis patients treated with SoluMatrix meloxicam report greater pain relief

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today will present Phase 3 results that showed osteoarthritis (OA) patients treated with investigational SoluMatrix meloxicam 5 mg and 10 mg, a low dose nonsteroidal anti-inflammatory drug (NSAID), reported significantly greater pain relief compared with placebo.

New findings provide insights into brain mechanisms underlying alcohol addiction

The human brain functions on a delicate balance of reinforcing positive behaviors and suppressing negative ones, which takes place in the dorsal striatum, a brain region critical for goal-directed behavior and implicated in drug and alcohol addiction.

Obesity measures are associated with higher risk for 10 cancers

Obesity increases the risk of developing 10 of the most common cancers, regardless of how it is measured, according to a study of more than 400,000 adults in the UK, being presented at The European Congress on Obesity (ECO) held online this year, with central fatness (larger waist and hips) and general obesity (body mass index [BMI] and body fat percentage) associated with similar estimates of cancer risk.

Read more Medical News

› Verified 6 days ago